About
Resonance Health Ltd is an Australian MedTech company focused on developing and commercializing non-invasive medical imaging analysis solutions for liver and heart conditions. The company specializes in precision MRI-based diagnostics, offering advanced imaging products that enhance clinical decision-making and patient management in hospitals, clinics, and pharmaceutical trials. Key products include FerriScan®, an FDA-approved technology for measuring liver iron concentration, and FerriSmart®, an AI-powered tool for evaluating liver iron levels. HepaFatSmart® quantifies liver fat using multiple metrics, while Cardiac T2® assesses heart iron overload. The company also provides high-quality MRI calibration phantoms and offers clinical trial imaging services, supporting pharmaceutical companies with precise imaging data. Resonance Health serves a diverse customer base, including healthcare providers, pharmaceutical companies, and research institutions, delivering reliable diagnostic tools and imaging services that contribute to improved patient care.
Technologies
Keywords
Company Information
-
Employees 18
-
Founded 2000
-
Annual Revenue $7239000
Location
141 Burswood Rd, Perth, Western Australia, Australia, 6100